These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1690316)

  • 21. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry.
    Lee AK; Dugan J; Hamilton WM; Cook L; Heatley G; Kamat B; Silverman ML
    Mod Pathol; 1991 Mar; 4(2):178-82. PubMed ID: 2047381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer.
    Visscher DW; Wykes S; Kubus J; Crissman JD
    Breast Cancer Res Treat; 1992; 22(2):111-8. PubMed ID: 1356517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between image cytometric DNA index, proliferation fraction and multiploidy and conventional nuclear grade in breast carcinoma.
    Smith FB; Zappi ME
    Mod Pathol; 1993 Sep; 6(5):606-11. PubMed ID: 7504261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy.
    Michels JJ; Duigou F; Marnay J; Denoux Y; Delozier T; Chasle J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):37-45. PubMed ID: 12949958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors.
    Longin A; Fontanière B; Pinzani V; Catimel G; Souchier C; Clavel M; Chauvin F
    Pathol Res Pract; 1992 Jun; 188(4-5):466-72. PubMed ID: 1409073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
    Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
    Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
    Ottestad L; Pettersen EO; Nesland JM; Hannisdal E; Fosså SD; Tveit KM
    Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.
    Cornelisse CJ; de Koning HR; Moolenaar AJ; van de Velde CJ; Ploem JS
    Anal Quant Cytol; 1984 Mar; 6(1):9-18. PubMed ID: 6732072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
    Redkar AA; Balsara BR; Bhisey AN; Sampat MB; Mittra I
    Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?
    Fernö M; Baldetorp B; Ewers SB; Idvall I; Olsson H; Sigurdsson H; Killander D
    Cytometry; 1992; 13(3):241-9. PubMed ID: 1576890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Flow cytometric cell cycle analysis using a monoclonal antibody to bromodeoxyuridine on gastric cancers].
    Ohyama S; Yonemura Y; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1848-54. PubMed ID: 2608014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA content analysis of Barrett's esophagus by flow cytometry.
    Sciallero S; Giaretti W; Bonelli L; Geido E; Rapallo A; Conio M; Ravelli P; Lombardo L; Briglia R; Lapertosa G
    Endoscopy; 1993 Nov; 25(9):648-51. PubMed ID: 8119224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.